We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Paracetamol should be taken as directed in the patient information leaflet.
Government rolling out Jess's Rule posters to all GP surgeries in England to act as reminder of a life-saving patient safety initiative.
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
Infected Blood Compensation Authority's update that was circulated on 15 January 2026
Waiting lists in 20 areas in England fall 3 times faster than the national average thanks to experts deployed by government to help supercharge NHS care.
The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK’s competitiveness for global clinical research.
Wes Streeting, Secretary of State for Health and Social Care, delivers a keynote speech on NHS reform at the Institute for Government's annual conference.
Healthcare industry innovator Dr Melanie Ivarsson has been appointed as CEO of the Health Data Research Service (HDRS) to accelerate medical breakthroughs.
Updated product information and packaging will help patients better understand the risks of dependency, addiction, and withdrawal with these medicines.
As medicines and medical technologies become more complex, there are exciting opportunities to further strengthen our safety monitoring systems.
As with any medicine, the MHRA will keep the safety and effectiveness of Nirogacestat hydrobromide under close review.
In this new role, Professor George will lead the Agency’s science strategy and will oversee the MHRA’s scientific, research and innovation activities.
Children will be protected from exposure to junk food ads under new regulations, in a bid to tackle childhood obesity.
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review.
A new £2 million pilot will see health visitors reach families facing barriers to vaccines, to ensure more children are protected.
More than 500 new ambulances will be deployed in England to cut response times for patients in every region.
Government launches consultation to help combat rising drug deaths from opioids, as part of record £3.4 billion in investment in drug and alcohol services.
As many people consider lifestyle changes at the start of the year, the Medicines and Healthcare products Regulatory Agency (MHRA) is urging the public to make sure any weight-loss medicines they use are safe, effective and …
As colder weather arrives, the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Fire Chiefs Council (NFCC) are urging the public to be aware of fire risks linked to emollient skin creams.
This festive season, one of the most important and life-saving gifts you can give your child is vaccination, and it’s completely free.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).